advertisement

Topcon

Journal of Ocular Pharmacology and Therapeutics 8

Showing records 1 to 8 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

22060 Role of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells
Husain S; Crosson CE
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 268-277
22061 Correlation between water-drinking test outcomes and body mass index in primary open-angle glaucoma patients under clinical treatment
Lima VC; Prata TS; Lobo RAB; Paranhos Jr A
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 513-516
22058 Latanoprost-induced changes in rat intraocular pressure: Direct or indirect?
Husain S; Yates PW; Crosson CE
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 367-372
22059 Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost
Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 517-520
22056 A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost
Sharpe ED; Williams RD; Stewart JA; Nelson LA; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 408-413
22055 Observational study results in glaucoma patients undergoing a regimen replacement to fixed combination travoprost 0.004%/timolol 0.5% in Germany
Arend K-O; Raber T
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 414-420
22062 Ferulic acid, but not tetramethylpyrazine, significantly attenuates retinal ischemia/reperfusion-induced alterations by acting as a hydroxyl radical scavenger
Chao H-M; Lin D-E; Chang Y; Hsu W-M; Lee S-M; Lee F-L; Chi C-W; Pan WHT; Liu T-Y; Lui W-Y
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 461-472
22057 H-1152 effects on intraocular pressure and trabecular meshwork morphology of rat eyes
Yu M; Chen X; Wang N; Cai S; Li N; Qiu J; Brandt CR; Kaufman PL; Liu X
Journal of Ocular Pharmacology and Therapeutics 2008; 24: 373-379

Issue 10-4

Change Issue


advertisement

Oculus